    <SEC-DOCUMENT>0001178913-23-001067-index.html : 20230321
    <SEC-HEADER>0001178913-23-001067.hdr.sgml : 20230321
    <ACCEPTANCE-DATETIME>20230321060201
    ACCESSION NUMBER:		0001178913-23-001067
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20221231
    FILED AS OF DATE:		20230321
    DATE AS OF CHANGE:		20230321
    EFFECTIVENESS DATE:		20230321

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
    		CENTRAL INDEX KEY:			0001534248
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		IRS NUMBER:				813676773
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38807
    		FILM NUMBER:		23747764

    	BUSINESS ADDRESS:
    		STREET 1:		KIRYAT ATIDIM, BUILDING 7
    		CITY:			TEL AVIV
    		STATE:			L3
    		ZIP:			6158002
    		BUSINESS PHONE:		972-77-331-0156

    	MAIL ADDRESS:
    		STREET 1:		KIRYAT ATIDIM, BUILDING 7
    		CITY:			TEL AVIV
    		STATE:			L3
    		ZIP:			6158002

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
    		DATE OF NAME CHANGE:	20180906

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	BioCancell Ltd.
    		DATE OF NAME CHANGE:	20111104
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>zk2329416.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: zk2329416.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>